Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Romidepsin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amneal Receives FDA Approval for Romidepsin Injection Solution
    Amneal Receives FDA Approval for Romidepsin Injection Solution

    04 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/04/3306692/0/en/amneal-announces-u-s-fda-approval-of-romidepsin-injection-solution.html

    GLOBENEWSWIRE
    04 Jun 2026
    Share Share
    Amneal’s Generics Romidepsin Receives Approval in US
    Amneal’s Generics Romidepsin Receives Approval in US

    02 Jun 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219099

    FDA
    02 Jun 2026
    Share Share
    Health Canada Issues Recall of Celgene Inc's ISTODAX (romidepsin) – Restricted Access Program
    Health Canada Issues Recall of Celgene Inc's ISTODAX (romidepsin) – Restricted Access Program

    20 Mar 2023

    // HEALTH CANADA

    https://recalls-rappels.canada.ca/en/alert-recall/istodax-romidepsin-restricted-access-program

    HEALTH CANADA
    20 Mar 2023
    Share Share
    Romidepsin for Injection Available from Fresenius Kabi
    Romidepsin for Injection Available from Fresenius Kabi

    12 Jul 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220712005418/en

    BUSINESSWIRE
    12 Jul 2022
    Share Share
    FDA officially pulls a BMS accelerated approval, and Teva copycat falls with it
    FDA officially pulls a BMS accelerated approval, and Teva copycat falls with it

    07 May 2022

    // Z. Brennan ENDPTS

    https://endpts.com/over-10-years-later-fda-officially-pulls-a-bms-accelerated-approval-and-a-teva-copycat-falls-with-it/

    Z. Brennan ENDPTS
    07 May 2022
    Share Share
    Fresenius Kabi`s Generic Romidepsin Receives Approval in the US
    Fresenius Kabi`s Generic Romidepsin Receives Approval in the US

    15 Oct 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206254

    FDA
    15 Oct 2021
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.